A trained immunologist, Miguel completed his PhD and Post-Doctoral positions at the University of Liverpool leading the investigations of mucosal immune responses to GSK human-licensed rotavirus vaccine and a norovirus vaccine candidate, and the translational development of RVX-001. Miguel’s expertise includes using preclinical in vivo models and ex vivo human cell-based and organoid assays to elucidate the immunogenicity and protective efficacy of novel vaccines and therapeutics. He is also an Honorary Research Associate at the University of Liverpool.